Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.
By Anil K. Chaturvedi, W. Anderson, J. Lortet-Tieulent, M. Curado, J. Ferlay, Silvia Franceschi, P. Rosenberg, F. Bray, M. Gillison. Journal of Clinical Oncology, 2013
1,242 citations recorded by the source corpus.
Subfields: Epidemiology, Genetics, Otorhinolaryngology
View Paper: https://www.semanticscholar.org/paper/4b06d22e501adefab5475084731caf2fef8b48ac
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Genetics
In Otorhinolaryngology
Citations in the corpus
- Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. (2016, background): “In North America, 56% of OPSCCs are HPV positive,(6) followed by 52% in Japan, 45% in Australia, 39% in northern and western Europe, and 13% in the rest of the world.(8,9) Patients with HPV-positive OPSCC are typically middle-aged, nonsmoking white men of higher socioeconomic status and with a histo”
- WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck (2020, background): “Squamous cell carcinoma of the head and neck (SCCHN) is a significant public health concern affecting over 50,000 patients annually in the United States [18].”
- A Web Tool for Age–Period–Cohort Analysis of Cancer Incidence and Mortality Rates (2014, neutral): “colleagues (41) examined oral cavity and oropharyngeal”
- The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012 (2017, background): “Despite the high incidence rates of oral cavity cancers, the overall incidence of such cancers has been decreasing in most parts of the world, which is consistent with decreases in tobacco and betel quid use.(9,41,101,102) However, the incidence of oropharyngeal cancers has been increasing, especial”
- Oral cavity and oropharyngeal squamous cell carcinoma—an update (2015, background): “Particularly in developed nations, a recent dramatic rise in HPV-related oropharyngeal cancer incidence has raised concerns of an emerging cancer epidemic.(6,8,73) Remarkably, in the United States, HPV has been estimated to account for approximately 16% of OP-SCCs in the early 1980s compared with >6”
- Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma (2023, background): “The prevalence of HPV-associated oropharyngeal cancer has increased in developing nations in recent years (225% in the US from 1984 to 2004), particularly among young adults [44].”